Aldeyra Therapeutics, Inc. (ALDX)
Data as of , from SEC Form 4 filings.
See up to 3 months of ALDX. The 7-day demo opens the 1M and 3M ranges and puts ALDX on your watchlist.
Start 7-day demoLatest ALDX insider trades
- Todd C. Brady - OfficerOpen-market purchase$418K
Richard DouglasOpen-market purchase$98K
About Aldeyra Therapeutics, Inc. (ALDX)
Aldeyra Therapeutics, Inc. files with the SEC under CIK 0001341235 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ALDX Form 4 activity by transaction type, last 90 days
No Form 4 activity for ALDX in the last 90 days.
ALDX insider transactions (Form 4)
3618 Form 4 filings on record, the earliest from Oct 21, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nancy Miller-Rich | Grant or award | Stock Option (Right to Buy) | 70,000 | $0.00 | - | |
| Nancy Miller-Rich | Grant or award | Stock Option (Right to Buy) | 3,318 | $0.00 | - | |
| Richard Douglas | Grant or award | Stock Option (Right to Buy) | 70,000 | $0.00 | - | |
| Richard Douglas | Grant or award | Stock Option (Right to Buy) | 19,909 | $0.00 | - | |
| Richard Douglas | Grant or award | Stock Option (Right to Buy) | 2,323 | $0.00 | - | |
| Gary M. Phillips | Grant or award | Stock Option (Right to Buy) | 70,000 | $0.00 | - | |
| Gary M. Phillips | Grant or award | Stock Option (Right to Buy) | 6,636 | $0.00 | - | |
| Gary M. Phillips | Grant or award | Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
| William D. Clark | Grant or award | Stock Option (Right to Buy) | 70,000 | $0.00 | - | |
| William D. Clark | Grant or award | Stock Option (Right to Buy) | 2,323 | $0.00 | - | |
 Neal Walker | Grant or award | Stock Option (Right to Buy) | 70,000 | $0.00 | - | |
| Neal Walker | Grant or award | Stock Option (Right to Buy) | 3,318 | $0.00 | - | |
| Ben Bronstein | Grant or award | Stock Option (Right to Buy) | 5,309 | $0.00 | - | |
| Ben Bronstein | Grant or award | Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
| Ben Bronstein | Grant or award | Stock Option (Right to Buy) | 70,000 | $0.00 | - | |
| Darlene M. Deptula-Hicks | Grant or award | Stock Option (Right to Buy) | 84,557 | $0.00 | - | |
| Darlene M. Deptula-Hicks | Grant or award | Stock Option (Right to Buy) | 9,756 | $0.00 | - | |
| Todd C. Brady - Officer | Open-market purchase | Common Stock | 250,000 | $1.67 footnote F1 | $418K | |
| ||||||
| Todd C. Brady - Officer | Grant or award | Stock Option (right to buy) | 1,880,510 | $0.00 | - | |
| Todd C. Brady - Officer | Grant or award | Bonus Units | 632,318 | $0.00 | - | |
| Richard Douglas | Open-market purchase | Common Stock | 70,000 | $1.40 | $98K | |
| Michael Alfieri - Officer | Open-market purchase | Common Stock | 5,000 | $1.42 | $7K | |
| Michael Alfieri - Officer | Open-market purchase | Common Stock | 2,500 | $5.30 | $13K | |
 Stephen Machatha - Officer | Open-market sale | Common Stock | 22,073 | $5.15 | $114K | |
| Martin Joseph Joyce | Grant or award | Stock Option (Right to Buy) | 62,728 | $0.00 | - | |
| Martin Joseph Joyce | Grant or award | Stock Option (Right to Buy) | 1,689 | $0.00 | - | |
| Martin Joseph Joyce | Grant or award | Stock Option (Right to Buy) | 7,238 | $0.00 | - | |
| Gary M. Phillips | Grant or award | Stock Option (Right to Buy) | 62,728 | $0.00 | - | |
| Gary M. Phillips | Grant or award | Stock Option (Right to Buy) | 4,825 | $0.00 | - | |
| Gary M. Phillips | Grant or award | Stock Option (Right to Buy) | 3,619 | $0.00 | - | |
| Richard Douglas | Grant or award | Stock Option (Right to Buy) | 62,728 | $0.00 | - | |
| Richard Douglas | Grant or award | Stock Option (Right to Buy) | 14,476 | $0.00 | - | |
| Richard Douglas | Grant or award | Stock Option (Right to Buy) | 1,689 | $0.00 | - | |
| PERCEPTIVE ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 3,400,000 | $1.42 | $4.83M | |
| Nancy Miller-Rich | Open-market purchase | Common Stock | 413 | $12.81 | $5K | |
| Nancy Miller-Rich | Open-market purchase | Common Stock | 509 | $10.13 | $5K | |
ALDX insider trading FAQ
What is the latest insider trade for ALDX?
Aldeyra Therapeutics, Inc. (ALDX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-11. The full record for ALDX runs to 18 Form 4 filings, the earliest from 2024-10-21. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ALDX stock?
No insider purchases of ALDX were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling ALDX stock?
No insider sales of ALDX were filed in the last 90 days. 2 sales are on record for this company.
Where can I see ALDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ALDX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Nancy Miller-Rich view on EDGAR
- - Richard Douglas view on EDGAR
- - Gary M. Phillips view on EDGAR
- - William D. Clark view on EDGAR
- - Neal Walker view on EDGAR
- - Ben Bronstein view on EDGAR
- - Darlene M. Deptula-Hicks view on EDGAR
- - Todd C. Brady view on EDGAR
- - Todd C. Brady view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ALDX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ALDX with a 7-day demo
- ALDX on your watchlist
- Every ALDX Form 4 filing on record
- Up to 3 months of ALDX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
